Biophysical tools to assess the interaction of PF4 with polyanions

被引:16
作者
Delcea, Mihaela [1 ,2 ,3 ]
Greinacher, Andreas [1 ]
机构
[1] Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, ZIK HIKE Ctr Innovat Competence Humoral Immune Re, Greifswald, Germany
[3] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany
基金
欧洲研究理事会;
关键词
Platelet factor 4; heparin; conformational changes; heparin-induced thrombocytopenia; biophysics of PF4/polyanion complexes; HEPARIN-INDUCED THROMBOCYTOPENIA; PLATELET FACTOR-IV; FACTOR 4/HEPARIN ANTIBODIES; FACTOR 4-HEPARIN COMPLEXES; CONFORMATIONAL-CHANGES; PLATELET-FACTOR-4; BINDING; FACTOR-4; PATHOGENESIS; BONDS;
D O I
10.1160/TH16-04-0258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antigen in heparin-induced thrombocytopenia (HIT) is expressed on platelet factor 4 (PF4) when PF4 complexes with polyanions. In recent years, biophysical tools (e.g. circular dichroism spectroscopy, atomic force microscopy, isothermal titration calorimetry, x-ray crystallography, electron microscopy) have gained an important role to complement immunological and functional assays for better understanding the interaction of heparin with PF4. This allowed identification of those features that make PF4 immunogenic (e.g. a certain conformational change induced by the polyanion, a threshold energy of the complexes, the existence of multimeric complexes, a certain number of bonds formed by PF4 with the polyanion) and to characterize the morphology and thermal stability of complexes formed by the protein with polyanions. These findings and methods can now be applied to test new drugs for their potential to induce the HIT-like adverse drug effect by preclinical in vitro testing. The methods and techniques applied to characterize the antigen in HIT may also be helpful to better understand the mechanisms underlying other antibody-mediated disorders in thrombosis and hemostasis (e.g. acquired hemophilia, thrombotic thrombocytopenic purpura). Furthermore, understanding the mechanisms making the endogenous protein PF4 immunogenic may help to understand the mechanisms underlying other autoimmune disorders.
引用
收藏
页码:783 / 791
页数:9
相关论文
共 44 条
[1]  
AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21
[2]   Characterization of bonds formed between platelet factor 4 and negatively charged drugs using single molecule force spectroscopy [J].
Block, Stephan ;
Greinacher, Andreas ;
Helm, Christiane A. ;
Delcea, Mihaela .
SOFT MATTER, 2014, 10 (16) :2775-2784
[3]   THE MULTIPLE COMPLEXES FORMED BY THE INTERACTION OF PLATELET FACTOR-4 WITH HEPARIN [J].
BOCK, PE ;
LUSCOMBE, M ;
MARSHALL, SE ;
PEPPER, DS ;
HOLBROOK, JJ .
BIOCHEMICAL JOURNAL, 1980, 191 (03) :769-776
[4]   Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria [J].
Brandt, Sven ;
Krauel, Krystin ;
Jaax, Miriam ;
Renne, Thomas ;
Helm, Christiane A. ;
Hammerschmidt, Sven ;
Delcea, Mihaela ;
Greinacher, Andreas .
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) :1189-1198
[5]   Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity [J].
Brandt, Sven ;
Krauel, Krystin ;
Gottschalk, Kay E. ;
Renne, Thomas ;
Helm, Christiane A. ;
Greinacher, Andreas ;
Block, Stephan .
THROMBOSIS AND HAEMOSTASIS, 2014, 112 (01) :53-64
[6]   Atomic description of the immune complex involved in heparin-induced thrombocytopenia [J].
Cai, Zheng ;
Yarovoi, Serge V. ;
Zhu, Zhiqiang ;
Rauova, Lubica ;
Hayes, Vincent ;
Lebedeva, Tatiana ;
Liu, Qun ;
Poncz, Mortimer ;
Arepally, Gowthami ;
Cines, Douglas B. ;
Greene, Mark I. .
NATURE COMMUNICATIONS, 2015, 6
[7]  
COWAN SW, 1986, BIOCHEM J, V234, P485, DOI 10.1042/bj2340485
[8]  
Delcea M, 2015, J THROMB HAEMOST, V13, P213
[9]  
GREINACHER A, 1995, THROMB HAEMOSTASIS, V74, P886
[10]   LABORATORY DIAGNOSIS OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA AND COMPARISON OF PLATELET-AGGREGATION TEST, HEPARIN-INDUCED PLATELET ACTIVATION TEST, AND PLATELET FACTOR-4 HEPARIN ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
GREINACHER, A ;
AMIRAL, J ;
DUMMEL, V ;
VISSAC, A ;
KIEFEL, V ;
MUELLERECKHARDT, C .
TRANSFUSION, 1994, 34 (05) :381-385